Temporary bypass device aims to protect surgical connections in colorectal cancer

NCT ID NCT05632744

Completed Disease control Sponsor: Colospan Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This trial tests a temporary device called CG-100 that is placed inside the intestine during colorectal cancer surgery. The device is designed to protect the surgical connection while it heals, potentially reducing leaks and other complications. The study includes adults aged 22 to 75 who have been diagnosed with colorectal cancer and are scheduled for surgery. The main goal is to check whether the device is safe by monitoring for serious side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CG-100 Intraluminal Bypass Device
What this could lead to: If safe and effective, this device could help protect the surgical connection during colorectal cancer surgery, potentially reducing complications and improving recovery.
What could go wrong: This is a very small early-stage safety study with only 7 participants, so results may not apply to all patients. The device itself carries risks such as infection or device-related injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER

Contacts and locations

Locations

Soroka Medical Center

Rehovot, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.